BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21677333)

  • 1. Hepatitis B virus infection has no significant role on lymphoproliferative disorders post liver transplantation: PTLD. int survey.
    Izadi M; Taheri S
    Ann Hepatol; 2011; 10(3):315-20. PubMed ID: 21677333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
    Khedmat H; Taheri S
    Exp Clin Transplant; 2012 Apr; 10(2):141-7. PubMed ID: 22432758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey.
    Izadi M; Taheri S
    Ann Transplant; 2011; 16(1):39-47. PubMed ID: 21436773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus reactivation is a risk factor for development of post-transplant lymphoproliferative disease after liver transplantation.
    Zhang A; Zhang M; Shen Y; Wang W; Zheng S
    Clin Transplant; 2009; 23(5):756-60. PubMed ID: 19664018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):235-42. PubMed ID: 23538344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
    Hsu CT; Chang MH; Ho MC; Chang HH; Lu MY; Jou ST; Ni YH; Chen HL; Hsu HY; Wu JF
    J Formos Med Assoc; 2019 Nov; 118(11):1537-1545. PubMed ID: 30630698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoproliferative disorders in pediatric liver allograft recipients: a review of 212 cases.
    Khedmat H; Taheri S
    Hematol Oncol Stem Cell Ther; 2012; 5(2):84-90. PubMed ID: 22828371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
    Izadi M; Fazel M; Saadat SH; Taheri S
    J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More benign lymphoproliferative disease after liver transplant in infants.
    Khedmat H; Ghamar-Chehreh ME; Amini M; Taheri S
    Prog Transplant; 2013 Jun; 23(2):158-64. PubMed ID: 23782664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus late outset of lymphoproliferative disorders post-heart and lung transplantation: the PTLD.Int Survey.
    Khedmat H; Taheri S
    Hematol Oncol Stem Cell Ther; 2011; 4(1):10-6. PubMed ID: 21460602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
    Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow involvement by lymphoproliferative disorders post liver transplantation: PTLD Int Survey.
    Khedmat H; Taheri S
    Acta Med Indones; 2012 Jul; 44(3):207-13. PubMed ID: 22983075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.
    Khedmat H; Taheri S
    Hematol Oncol Stem Cell Ther; 2011; 4(2):73-80. PubMed ID: 21727768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allograft involvement by lymphoproliferative disorders after lung transplantation: report from the PTLD. Int survey.
    Izadi M; Taheri S
    Prog Transplant; 2011 Dec; 21(4):353-9. PubMed ID: 22549000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: report from the PTLD.Int Survey.
    Izadi M; Taheri S
    Ann Transplant; 2010; 15(4):102-9. PubMed ID: 21183884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
    Khedmat H; Taheri S
    Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H; Taheri S
    Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
    Kim RD; Fujikawa T; Mizuno S; Schwartz JJ; Sorensen JB; Hemming AW; Fujita S
    Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):559-65. PubMed ID: 21555941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplantation lymphoproliferative disorders in renal vs. simultaneous renal-pancreas allograft recipients: a survey and analysis of data from the literature.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):1-7. PubMed ID: 23354184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.